Margaret: CAR-T Bridging to Transplant in T-ALL
2026-3-24Margaret never expected that a routine blood test during pregnancy would change everything. What started as a standard check quickly led to a diagnosis of T-cell acute lymphoblastic leukemia—an aggressive and complex disease.
She began treatment in her home country and responded well at first. But her journey soon became unpredictable. After giving birth, the disease returned, this time involving her central nervous system. Even after multiple rounds of treatment, it continued to come back.
Looking for new options, Margaret traveled to GoBroad Healthcare Group.
Under the leadership of Dr. Yajing Zhang, the medical team designed a CD7 CAR-T cell therapy approach tailored to Margaret’s condition. This treatment helped bring her disease back under control and provided a much-needed period of stability, though her journey was far from over.
Over the following months, Margaret faced one challenge after another—relapse, complications from treatment, and severe infections involving multiple pathogens. At one point, her condition became extremely fragile. Managing the disease was no longer just about fighting leukemia, but also about helping her body withstand everything that came with it.
Throughout this time, a multidisciplinary team worked closely together to support her. Treatments were adjusted constantly. Infections were addressed one by one. Every small improvement mattered.
As her condition gradually stabilized and remission was achieved again, Margaret was successfully transitioned to the Hematopoietic Stem Cell Transplant Center at GoBroad. There, she proceeded to a stem cell transplant using her father as a haploidentical donor—an essential step offering the best chance for long-term disease control. The transplant was not without risks, but Margaret held on. With careful monitoring and continuous support, she made it through the most difficult phase.
By the time she was ready to leave the transplant unit, her condition was stable, her infections were under control, and there was no sign of active disease. Before she left, Margaret wrote a short-handwritten note to the team who had cared for her. There were no long speeches—just simple words of thanks.

But behind those words was everything she had been through: uncertainty, resilience, and the quiet determination to keep going. At GoBroad Healthcare Group, stories like Margaret’s are not just about treatment—they are about partnership, trust, and the strength it takes to move forward, one step at a time.







